Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
Cancers|July 9, 2022
Prognostic and Predictive Role of Body Composition in Metastatic Neuroendocrine Tumor Patients Treated with Everolimus: A Real-World Data AnalysisNicoletta Ranallo, Andrea Prochoswski Iamurri, Flavia Foca, et al.
European Journal of Cancer (Oxford, England : 1990)|July 13, 2024
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomasAlberto Bongiovanni, Chiara Liverani, Flavia Foca, et al.
Endocrine Connections|September 2, 2016
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease managementKjell Oberg, Eric Krenning, Anders Sundin, et al.
Tumori|September 15, 2025
The use of bone-modifying agents in early breast cancer: AIOM Guidelines update and perspectivesAlberto Zambelli, Riccardo Gerosa, Michela Cinquini, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 2, 2015
Human-based approaches to pharmacology and cardiology: an interdisciplinary and intersectorial workshopBlanca Rodriguez, Annamaria Carusi, Najah Abi-Gerges, et al.
Clinical Pharmacology and Therapeutics|November 12, 2019
General Principles for the Validation of Proarrhythmia Risk Prediction Models: An Extension of the CiPA In Silico StrategyZhihua Li, Gary R Mirams, Takashi Yoshinaga, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 4, 2020
Impact of liver tumour burden, alkaline phosphatase elevation, and target lesion size on treatment outcomes with 177Lu-Dotatate: an analysis of the NETTER-1 studyJonathan Strosberg, Pamela L Kunz, Andrew Hendifar, et al.
JAMA Network Open|February 24, 2022
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine TumorsSara Pusceddu, Natalie Prinzi, Salvatore Tafuto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2022
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastomaMatt Lechner, Yoko Takahashi, Mario Turri-Zanoni, et al.
Pageof 13